Ingredion's Sells Nearly Shares: CEO Liquidates Stake Over $1M
When a CEO sells a large block of stock, investors take notice. This article breaks down Ingredion's recent insider m...
Ways To Keep Saving Fun And Engaging
Saving money doesn't have to be dull! Explore creative ways to keep your savings journey enjoyable and engaging.
28,655 articles
Building Fair Sports Exchange: PRED CEO Interview Insights
PRED is pushing a true peer-to-peer sports exchange model, removing the house edge and aligning trader incentives. Th...
Top Performing Stocks Shine as Markets Rally in March 2026
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...
Moody’s Puts Odds of Recession at Fifty Percent Now
Moody’s Analytics now sees a near-even chance of a U.S. recession within the next year, as energy shocks and a coolin...
Two Harbors Scraps UWM Deal, Accepts Cash Bid From CCM
Two Harbors Investment will terminate its merger with UWM and accept an all-cash bid from CrossCountry worth roughly ...
Homebuilder Consolidation Heats with Dream Finders Bid
Dream Finders' unsolicited cash offer values Beazer at about $704 million, sparking a public contest as U.S. homebuil...
Northwestern Mutual 2025 Study Finds 61% Without Wills
A new northwestern mutual 2025 study shows most Americans have no will, with Gen X and Baby Boomers lagging in estate...
Billionaire Mark Cuban Says Bye to Bitcoin as Crypto Disappoints
Billionaire Mark Cuban says crypto has disappointed him, selling most of his Bitcoin, while Ethereum holds some appea...
Dubai Property Prices Down: War Shock or Lasting Trend
Dubai's property market is cooling as buyers pull back and prices fall. Analysts weigh whether the dip is a temporary...
Famous Wall Street Futurist Backs Starlink-Only IPO Valuation
A famous wall street futurist contends Starlink’s subscription revenue alone could underpin SpaceX’s multi-trillion-d...
Forget Volatility: A Core Portfolio Cornerstone to Buy
As markets wobble in 2026, investors are turning to a core portfolio cornerstone built on durable, recurring revenue....
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status